However, when the researchers adjusted for other things , including siblings with autism, the increased risk was no longer statistically significant .[ref][ref] (Note that other researchers point out bias in that paper.[ref]) Another large study published in 2021 involving 73,000 children and mothers found that there was a 19% increase in relative risk of ASD with prenatal acetaminophen exposure.[ref] A 2025 meta-analysis of studies on acetaminophen use during pregnancy and infancy shows that the majority of studies and the higher-quality studies show a positive association between acetaminophen use and ADHD, ASD, or neurodevelopmental disorders.[ref] A couple of things to consider here

The slower erosion curve for biologics (20-30% biosimilar market share after two years, versus 80-90% for small molecules) means that even after formal loss of exclusivity, the price compression that Cost Plus needs to add a drug to its formulary at a meaningful patient savings may not materialize for three to four years post-LOE
For instance, one study notes that people with excess weight or obesity appear to have lower vitamin B12 levels than people who have a body mass index (BMI) in the normal range ( Additional research has observed that people who voluntarily took vitamin B12 supplements gained between 2.517 fewer pounds (1.27.7 kg) over 10 years than those who did not supplement with this vitamin ( Still, such observational studies cannot confirm whether low vitamin B12 levels are what caused the weight gain, nor whether theyre what protected against low levels
"There are now effective drugs, and this could lead to higher labor productivity, gains in longevity, and potentially reduce medical costs costs elsewhere in the health system." Columbia Threadneedle Investments reported that the weight-loss drug industry could become a $1.7 trillion annual market if 100 million Americans took GLP-1s at their current price
However, if youre vegan, vegetarian, or have absorption issues, food alone may not be enough
Effects of LHRH-analogues on mitogenic signal transduction in cancer cells